Previous 10 | Next 10 |
The recent market pullback was arguably overdue and is already making stocks attractive for longer-term investors. Insiders are giving excellent industry signals to act on and numerous specific stocks to consider. Take your pick of insider-approved energy, bank, income, infrastruc...
Radnor, Pennsylvania--(Newsfile Corp. - January 24, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO). The action c...
Pharma/biotech is the most attractive subsector. The most overvalued one is life science tools. IXJ: an alternative to XLV. 10 stocks cheaper than their peers in December. For further details see: IXJ: Healthcare Dashboard For December
NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) in the United States District Court for the Easter...
CANTON, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
New York, New York--(Newsfile Corp. - November 14, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Organogenesis ("Organogenesis Holdings Inc." or the "Company") (NASDAQ: ORGO). If you suffered losses exceeding $50,000 inves...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Organogenesis To Contact Him Directly To Discuss Their Options NEW YORK - ( NewMediaWire ) - November 12, 2021 - Faruqi & Faruqi, LLP, a leading national securities law fi...
Image source: The Motley Fool. Organogenesis Holdings Inc (NASDAQ: ORGO) Q3 2021 Earnings Call Nov 09, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis Holdings Inc (ORGO) Q3 2021 Earnings Call Transcri...
Organogenesis Holdings Inc. (ORGO) Q3 2021 Results Conference Call November 09, 2021 05:00 PM ET Company Participants Gary Gillheeney - President and Chief Executive Officer David Francisco - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Matt Miksic - Credit Suiss...
CANTON, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...